At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AVTE Aerovate Therapeutics, Inc.
Post-Market Trading 11-26 18:46:55 EST
2.68
+0.00
0.00%
盘后2.68
+0.000.00%
16:02 EST
High2.73
Low2.62
Vol165.02K
Open2.64
D1 Closing2.68
Amplitude3.91%
Mkt Cap77.38M
Tradable Cap31.77M
Total Shares28.87M
T/O442.47K
T/O Rate1.39%
Tradable Shares11.85M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Calendar of U.S. Earnings Expected in the Week Ahead
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.